These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 7413650)
1. The therapeutic role of methylphenidate in senile organic brain syndrome. Branconnier RJ; Cole JO Proc Annu Meet Am Psychopathol Assoc; 1980; 69():183-96. PubMed ID: 7413650 [No Abstract] [Full Text] [Related]
2. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Lee H; Kim SW; Kim JM; Shin IS; Yang SJ; Yoon JS Hum Psychopharmacol; 2005 Mar; 20(2):97-104. PubMed ID: 15641125 [TBL] [Abstract][Full Text] [Related]
3. Does methylphenidate reduce the symptoms of chronic fatigue syndrome? Blockmans D; Persoons P; Van Houdenhove B; Bobbaers H Am J Med; 2006 Feb; 119(2):167.e23-30. PubMed ID: 16443425 [TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077 [TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of senile dementia. Reisberg B; Ferris SH; Gershon S Proc Annu Meet Am Psychopathol Assoc; 1980; 69():233-64. PubMed ID: 6997869 [No Abstract] [Full Text] [Related]
14. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. Bruera E; Driver L; Barnes EA; Willey J; Shen L; Palmer JL; Escalante C J Clin Oncol; 2003 Dec; 21(23):4439-43. PubMed ID: 14645434 [TBL] [Abstract][Full Text] [Related]
15. Effect of magnesium pemoline and methylphenidate on memory improvement and mood in normal aging subjects. Gilbert JG; Donnelly KJ; Zimmer LE; Kubis JF Int J Aging Hum Dev; 1973; 4(1):35-51. PubMed ID: 4591659 [No Abstract] [Full Text] [Related]
16. Symptom clusters in patients with newly-diagnosed brain tumors. Gleason JF; Case D; Rapp SR; Ip E; Naughton M; Butler JM; McMullen K; Stieber V; Saconn P; Shaw EG J Support Oncol; 2007 Oct; 5(9):427-33, 436. PubMed ID: 18019850 [TBL] [Abstract][Full Text] [Related]
17. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Research Units on Pediatric Psychopharmacology Autism Network Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814 [TBL] [Abstract][Full Text] [Related]
18. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Spencer T; Biederman J; Wilens T; Doyle R; Surman C; Prince J; Mick E; Aleardi M; Herzig K; Faraone S Biol Psychiatry; 2005 Mar; 57(5):456-63. PubMed ID: 15737659 [TBL] [Abstract][Full Text] [Related]
19. Clinical and biological aspects of depression in the elderly. Klein DF Proc Annu Meet Am Psychopathol Assoc; 1980; 69():197-203. PubMed ID: 7413652 [No Abstract] [Full Text] [Related]
20. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial. Nutt JG; Carter JH; Carlson NE Arch Neurol; 2007 Mar; 64(3):319-23. PubMed ID: 17353373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]